The US FDA has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

This bipartisan legislation would ensure that Medicare covers non-opioid pain medications, giving seniors access to safer treatment options without facing higher costs or hoops to jump through.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

For most people who treat cancer pain with opioids, the drugs do not lead to misuse, but they may cause temporary fogginess and fatigue. A doctor can inject a treatment known as a celiac plexus ...

The Food and Drug Administration (FDA) hasn’t approved any medications containing CBD for pain relief, and additional research is necessary to determine CBD’s ability to reduce pain ...

Others are used to manage resulting symptoms like pain, depression, and muscle stiffness. There are several types of medications that can be used to treat MS, including chemotherapy drugs, ...

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

(NEW YORK) — The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called ...